Jan M. Prins

29.6k total citations · 2 hit papers
402 papers, 11.6k citations indexed

About

Jan M. Prins is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Jan M. Prins has authored 402 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 190 papers in Epidemiology, 176 papers in Infectious Diseases and 113 papers in Virology. Recurrent topics in Jan M. Prins's work include HIV Research and Treatment (113 papers), HIV/AIDS Research and Interventions (112 papers) and HIV/AIDS drug development and treatment (87 papers). Jan M. Prins is often cited by papers focused on HIV Research and Treatment (113 papers), HIV/AIDS Research and Interventions (112 papers) and HIV/AIDS drug development and treatment (87 papers). Jan M. Prins collaborates with scholars based in Netherlands, United States and Canada. Jan M. Prins's co-authors include Peter Speelman, Ed J. Kuijper, Marlies Hulscher, Suzanne Jurriaans, Joep M. A. Lange, Suzanne E. Geerlings, Henry J.C. de Vries, Pythia T. Nieuwkerk, Jerôme A. Lindeboom and Jeroen Schouten and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Medicine.

In The Last Decade

Jan M. Prins

391 papers receiving 11.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis

2016 508 citations Marlies Hulscher, Paul D. van der Linden et al. profile →
Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial

2023 70 citations Suzanne E. Geerlings, Jan M. Prins et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan M. Prins Netherlands	57	5.0k	4.4k	2.6k	1.5k	1.3k	402	11.6k
Roberto Cauda Italy	53	4.0k 0.8×	5.5k 1.3×	2.1k 0.8×	1.5k 1.0×	759 0.6×	330	12.2k
Matthew Bidwell Goetz United States	51	4.2k 0.8×	3.8k 0.9×	1.5k 0.6×	592 0.4×	739 0.6×	274	9.2k
Robert A. Salata United States	49	2.5k 0.5×	3.7k 0.8×	1.1k 0.4×	544 0.4×	812 0.6×	239	8.3k
Marilyn M. Wagener United States	65	8.0k 1.6×	8.6k 2.0×	1.2k 0.5×	1.3k 0.8×	1.6k 1.2×	171	17.1k
A. Sarah Walker United Kingdom	55	2.8k 0.6×	4.9k 1.1×	876 0.3×	720 0.5×	711 0.5×	264	10.5k
Carlo Giaquinto Italy	52	2.6k 0.5×	5.4k 1.2×	2.4k 0.9×	362 0.2×	466 0.3×	360	9.5k
Mike Sharland United Kingdom	58	4.9k 1.0×	2.4k 0.6×	529 0.2×	3.1k 2.0×	563 0.4×	367	11.5k
William Schaffner United States	73	11.7k 2.4×	5.1k 1.2×	491 0.2×	709 0.5×	1.2k 0.9×	453	21.1k
Patrizio Pezzotti Italy	54	3.3k 0.7×	4.8k 1.1×	1.9k 0.7×	517 0.3×	472 0.4×	289	10.6k
David A. Talan United States	44	3.3k 0.7×	6.6k 1.5×	795 0.3×	855 0.6×	1.3k 1.0×	136	12.0k

Countries citing papers authored by Jan M. Prins

Since Specialization

Citations

This map shows the geographic impact of Jan M. Prins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan M. Prins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan M. Prins more than expected).

Fields of papers citing papers by Jan M. Prins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan M. Prins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan M. Prins. The network helps show where Jan M. Prins may publish in the future.

Co-authorship network of co-authors of Jan M. Prins

This figure shows the co-authorship network connecting the top 25 collaborators of Jan M. Prins. A scholar is included among the top collaborators of Jan M. Prins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan M. Prins. Jan M. Prins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wit, Ferdinand W.N.M., Vita W. Jongen, Kees Brinkman, et al.. (2025). Earlier Initiation of Treatment Following HIV Acquisition Reduces Non-AIDS-defining Malignancy Risk. Clinical Infectious Diseases.

Linden, Paul D. van der, Jan Jelrik Oosterheert, Elske Sieswerda, et al.. (2025). Short-course aminoglycosides as adjunctive treatment in adults with sepsis: A post-hoc analysis of a prematurely terminated cluster randomized trial. University of Groningen research database (University of Groningen / Centre for Information Technology). 2(2). 105075–105075.

Geijsen, Debby, Philip Meijnen, Birgit I. Lissenberg‐Witte, et al.. (2024). DNA Methylation Analysis on Anal Swabs for Anal Cancer Screening in People Living With Human Immunodeficiency Virus. The Journal of Infectious Diseases. 232(5). 1040–1049. 3 indexed citations

Wynberg, Elke, Alvin X. Han, Hugo D.G. van Willigen, et al.. (2024). Inflammatory profiles are associated with long COVID up to 6 months after COVID-19 onset: A prospective cohort study of individuals with mild to critical COVID-19. PLoS ONE. 19(7). e0304990–e0304990. 4 indexed citations

Vaart, Thomas W. van der, Jan M. Prins, Cornelis H. van Werkhoven, et al.. (2023). Positive Impact of [18F]FDG-PET/CT on Mortality in Patients With Staphylococcus aureus Bacteremia Explained by Immortal Time Bias. Clinical Infectious Diseases. 77(1). 9–15. 13 indexed citations

Visser, Caroline E., et al.. (2023). Population pharmacokinetic/pharmacodynamic target attainment of ceftriaxone 2 g once daily in non‐critically ill hospitalized adult patients during the acute phase of infection. British Journal of Clinical Pharmacology. 89(11). 3262–3272.

Burg, Sjoerd H. van der, Marij J.P. Welters, Nikki M. Loof, et al.. (2023). Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of High-Grade Anal Intraepithelial Neoplasia in HIV+ Men. Clinical Cancer Research. 29(20). 4109–4117. 5 indexed citations

Bent, Sebastiaan A. S. van der, et al.. (2020). Spontaneous resolution of multidrug‐resistant Mycobacterium abscessus infection in tattoo. Journal of the European Academy of Dermatology and Venereology. 35(5). e328–e330. 3 indexed citations

Marra, Elske, Matthijs L. Siegenbeek van Heukelom, Tim Waterboer, et al.. (2018). Virological and Serological Predictors of Anal High-grade Squamous Intraepithelial Lesions Among Human Immunodeficiency Virus–positive Men Who Have Sex With Men. Clinical Infectious Diseases. 68(8). 1377–1387. 10 indexed citations

10.

Hulscher, Marlies, Ronald B. Geskus, T.M. De Reijke, et al.. (2018). [Better antibiotic use in complicated urinary tract infections; multicentre cluster randomised trial of 2 improvement strategies].. PubMed. 160. D460–D460. 2 indexed citations

11.

Coul, Eline Op de, Ard van Sighem, M Hillebregt, et al.. (2017). [Mapping HIV prevalence in the Netherlands with geographic information systems].. PubMed. 161. D965–D965. 6 indexed citations

12.

Prins, Jan M., et al.. (2017). Non-targeted HIV screening in emergency departments in the Netherlands.. PubMed. 75(9). 386–393. 8 indexed citations

13.

Richel, Olivier, et al.. (2016). Human papillomavirus as a cause of anal cancer and the role of screening. Current Opinion in Infectious Diseases. 30(1). 87–92. 26 indexed citations

14.

Quint, Koen D., J. Lindeman, C. J. M. van Noesel, et al.. (2014). One Lesion, One Virus: Individual Components of High-Grade Anal Intraepithelial Neoplasia in HIV-Positive Men Contain a Single HPV Type. The Journal of Infectious Diseases. 210(1). 111–120. 22 indexed citations

15.

Geerlings, Suzanne E., Marlies Hulscher, & Jan M. Prins. (2014). [Appropriate use of antibiotics shortens length of hospital stay].. PubMed. 158. A7288–A7288. 4 indexed citations

16.

Grady, Bart, Nening M. Nanlohy, Jan M. Prins, & Debbie van Baarle. (2013). 333 HCV-INFECTION IS NOT A MAJOR DETERMINANT OF IMMUNESENESCENCE IN AGING DRUG USERS. Journal of Hepatology. 58. S139–S139.

17.

Matser, Amy, Joost W. Vanhommerig, Maarten F. Schim van der Loeff, et al.. (2013). Correction: HIV-Infected Men Who Have Sex with Men Who Identify Themselves as Belonging to Subcultures Are at Increased Risk for Hepatitis C Infection. PLoS ONE. 8(4). 1 indexed citations

18.

Verheij, Theo, et al.. (2012). Samenvatting van de NHG-standaard 'Acuut hoesten'. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 156. 1 indexed citations

19.

Burger, David M., Patricia W. H. Hugen, Peter Reiss, et al.. (2003). Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals. AIDS. 17(8). 1157–1165. 119 indexed citations

20.

Repping, Sjoerd, et al.. (2002). Pharmacokinetic profiles of nevirapine and indinavir in various fractions of seminal plasma (vol 45, pg 2902, 2001). Data Archiving and Networked Services (DANS).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact